Ir directamente a la información del producto
1 de 1

Upajak 15mg tablet(Upadacitinib INN 15 mg)

Upajak 15mg tablet(Upadacitinib INN 15 mg)

Ver todos los detalles
Packaging Size: 30 tablets in an HDPE container
Strength: 15 mg
Composition: Upadacitinib INN 15 mg per extended-release film-coated tablet
Treatment: JAK inhibitor used for rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and polyarticular juvenile idiopathic arthritis, according to the applicable indication
Form: Extended-release film-coated tablet
Brand: Upajak 15 mg
Quantity Unit: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Upajak 15 mg Tablet (Upadacitinib INN 15 mg) is an oral Janus kinase (JAK) inhibitor used to reduce abnormal immune-system activity and inflammation. It is indicated for several chronic inflammatory and autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn’s disease, ankylosing spondylitis, and non-radiographic axial spondyloarthritis, depending on the patient’s age and clinical condition. Upajak contains upadacitinib 15 mg in an extended-release film-coated tablet and is manufactured by Everest Pharmaceuticals Ltd.

Everyone Deserves Access to Life-saving Treatment Of Cancer. We are a Trusted Cancer Medicine seller delivering certified medications to every corner of the world.